-
EFFECTIVENESS OF PHYSIOTHERAPY INTERVENTION AND ANALYSIS OF FACTORS INFLUENCING REHABILITATION AMONG INFANTS DIAGNOSED WITH MUSCULAR TORTICOLLIS
Aug 11, 2026, 17:16 PM -
KEY CONSIDERATIONS FOR THE DEVELOPMENT OF A NICE REFERENCE CASE EXTENSION IN MENTAL HEALTH DISORDERS
Aug 11, 2026, 17:16 PM -
INCORPORATING ENVIRONMENTAL IMPACT INTO COST-UTILITY ANALYSIS: A PROOF-OF-CONCEPT APPLICATION IN SEVERE ASTHMA BIOLOGICS
Aug 11, 2026, 17:16 PM -
FROM EVIDENCE TO CONSENSUS: DEVELOPING A SET OF INDICATORS FOR A COMPREHENSIVE SOCIAL SUSTAINABILITY ASSESSMENT IN THE HEALTHCARE VALUE CHAIN
Aug 11, 2026, 17:16 PM -
PATIENT-REPORTED HEALTH-RELATED QUALITY OF LIFE IN RHEUMATOID ARTHRITIS: BIOLOGIC VERSUS CONVENTIONAL DMARD THERAPY IN EGYPT
Aug 11, 2026, 17:16 PM -
MEDICINE-ACCESS PREFERENCES ACROSS COMMON COLD AND HYPERTENSION TREATMENT CONTEXTS IN CHINA: A WITHIN-SUBJECT DISCRETE CHOICE EXPERIMENT
Aug 11, 2026, 17:16 PM -
STRENGTHENING DIAGNOSTIC VALIDITY IN COMMUNITY-RECRUITED DIGITAL REAL-WORLD STUDIES: A METHODOLOGICAL REVIEW
Aug 11, 2026, 17:16 PM -
EVALUATION OF CASCADE GENETIC TESTING FOR BRCA1/2 MUTATION CARRIERS IN ITALY: A SEMI-MARKOV SIMULATION STUDY
Aug 11, 2026, 17:16 PM -
THE RISE OF OUT-OF-POCKET PAYMENT FOR GLP-1 THERAPIES: IMPLICATIONS FOR TRADITIONAL PHARMACEUTICAL REIMBURSEMENT AND MARKET ACCESS IN EUROPE
Aug 11, 2026, 17:16 PM -
MULTI-COUNTRY SURGEONS-REPORTED REAL WORLD EXPERIENCE WITH A PREMIUM IOL
Aug 11, 2026, 17:16 PM -
COMMONALITIES IN DISEASE BURDEN AND UNMET NEED IN UNDERSERVED AUTOIMMUNE DISEASES
Aug 11, 2026, 17:16 PM -
ECONOMIC IMPACT OF BIMEKIZUMAB FOR MODERATE TO SEVERE PLAQUE PSORIASIS IN FRANCE
Aug 11, 2026, 17:16 PM -
THE COST OF DIABETES CARE: HEALTHCARE SPENDING AND TREATMENT UTILIZATION AMONG DAMAN BENEFICIARIES IN SAUDI ARABIA
Aug 11, 2026, 17:16 PM -
COMPARATIVE EFFICACY OF APPROVED IL-17 INHIBITORS FOR MODERATE-TO-SEVERE PLAQUE PSORIASIS: A SYSTEMATIC LITERATURE REVIEW & BAYESIAN NETWORK META-ANALYSIS
Aug 11, 2026, 17:16 PM -
ACCOUNTING FOR HIGH PLACEBO RESPONSE IN HEALTH TECHNOLOGY ASSESSMENT: EVIDENCE FROM NICE TECHNOLOGY APPRAISALS AND LESSONS FOR RCTS AND ECONOMIC MODELING FOR SJOGREN'S DISEASE
Aug 11, 2026, 17:16 PM -
PICO DIVERGENCE AND EVIDENCE FEASIBILITY IN EU JOINT CLINICAL ASSESSMENTS: INSIGHTS FROM PUBLISHED SCOPING EXERCISES AND THE FIRST TOVORAFENIB ASSESSMENT
Aug 11, 2026, 17:16 PM -
FIVE YEARS OF THE FIFARMA W.A.I.T. INDICATOR: A LONGITUDINAL ANALYSIS OF ONCOLOGY AND ORPHAN DRUG ACCESS IN LATIN AMERICA (2022-2026)
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS AND PRICING OF AI TECHNOLOGY FOR READING MAMMOGRAMS IN THE ENGLAND NHS BREAST SCREENING PROGRAM
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS MODELS OF LUNG CANCER SCREENING BY LDCT IN EUROPE FROM 2015 TO 2026: A SYSTEMATIC REVIEW AND METHODOLOGICAL ASSESSMENT ADAPTED FOR FRANCE
Aug 11, 2026, 17:16 PM -
RELEVANCE OF BLOCKBUSTERS FOR THE PHARMACEUTICAL INDUSTRY
Aug 11, 2026, 17:16 PM
